In a trial, 25mg of psilocybin put patients in a dreamlike state, making therapy more likely to succeed.
, 1mg, 10mg and 25mg doses were tested on a total of 233 people from 10 countries in Europe and North America, with 25mg giving the best results.Most had been severely depressed for more than a year and were aged around 40, the researchers, from the Institute of Psychiatry, Psychology and Neuroscience at King's College London and South London and Maudsley NHS Foundation Trust, said.
"Patients go from 'What is wrong with me?' to 'What happened to me?'" psychotherapist Nadav Liam Modlin said. University of Edinburgh head of psychiatry Prof Andrew McIntosh said the trial provided "the strongest evidence so far to suggest that further, larger and longer randomised trials of psychedelics are justified".
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Magic mushroom' treatment for depression inches closer to approvalA large trial suggests the hallucinogen in magic mushrooms could treat severe depression.
Read more »
Magic Mushroom Psychedelic Relieves Severe Depression in Largest Trial YetFor some years now, scientists have been investigating how psilocybin, the psychedelic compound in magic mushrooms, can ease the symptoms of depression.
Read more »
Psychedelic ‘magic mushroom’ drug may ease some depressionThe psychedelic chemical in “magic mushrooms” may ease depression in some hard-to-treat patients.
Read more »
Synthetic 'magic mushroom' drug may ease depression in hard-to-treat patients, study saysA single dose of psilocybin, the hallucinogenic compound found in “magic mushrooms,” was found to help some people who previously had gotten little relief from standard antidepressants.
Read more »
Study: Synthetic 'magic mushroom' can help treat depressionAccording to the results of a phase 2 double-blind trial that were published in the New England Journal of Medicine, psilocybin improved rates of depression in the study's participants.
Read more »